New article on TargomiRs

May 26, 2016

ADRI scientists and collaborators have published a special report on the clinical development of their microRNA-based treatment for mesothelioma. This report describes microRNA replacement therapy for cancer and the concept behind TargomiRs in the MesomiR-1 trial. It appears in the journal Epigenomics and can be found here